| 1 |
16047355 | Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1. | 2005 Sep 15 |
2 |
| 2 |
11788908 | Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238. | 2002 Feb |
1 |
| 3 |
11290438 | A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice. | 2001 Mar |
6 |
| 4 |
11571730 | Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238. | 2001 Sep 1 |
4 |
| 5 |
10690557 | Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238. | 2000 Feb |
4 |
| 6 |
10850448 | Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238. | 2000 Jun 1 |
3 |
| 7 |
9465096 | Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. | 1998 Feb 17 |
1 |